NCT06030180 - CLUE: CLinical Utility Study of EsoGuard | Biotech Hunter

Enrollment

566

Participants

Timeline

Start Date

February 23, 2023

Primary Completion Date

December 13, 2024

Study Completion Date

December 13, 2024

Conditions

Barrett EsophagusBarretts Esophagus With DysplasiaEsophagus Adenocarcinoma

Interventions

DEVICE

EsoGuard

EsoGuard is a set of genetic assays and algorithms for the assessment of specific methylation patterns of DNA encoding the genes vimentin (VIM) and cyclin A1 (CCNA1)

Trial Locations (8)

31406

Savii Health, Savannah

72543

Arkansas Heartburn Treatment Center, Heber Springs

75224

James E Race, Dallas

77384

Gastroenterology Partners of North Houston, PLLC, Shenandoah

78550

Texas Digestive Specialists, Harlingen

80004

Arvada West Family Medicine,, Arvada

80120

Colorado Primary Healthcare, Littleton

84042

Premier Family Medical, Lindon